SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Evan Dimmer who wrote (4517)1/14/1998 4:04:00 PM
From: Tunica Albuginea  Read Replies (1) of 23519
 
Eva, Re:ICOS.Yes I've heard of this (tune ), and like this tune, ,gg, co before:

" ICOS' research and drug
development programs involve both acute and chronic conditions such as ARDS, acute pancreatitis,
asthma, hemorrhagic shock, male erectile dysfunction, multiple sclerosis, myocardial infarction, and
psoriasis.".
If lay investors only knew how absurdly complex all these diseases
are and how little we know about them, they would definitely not be
buying shares of all these little 2X2 biotech firms and pour money
in their stock,down a drain.

TA
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext